Public Policy

One of the Alliance’s most important missions is to advocate for aging research by working with legislators, health experts and other like-minded organizations. Our public policy efforts are summarized here.

Press Room

Leading Experts Discuss Clinical Meaningfulness in Drug Development for Early Alzheimer’s Disease

Author: Noel Lloyd

Date: November 6th, 2014

ACT-AD Coalition Hosts Its 7th Annual Meeting


Treatments to Slow Aging and Stymie Chronic Disease in Older Adults on the Horizon

Author: Noel Lloyd

Date: September 19th, 2014

Nonprofit Leader Dan Perry to Offer Insights at MipTec European Health Care Innovation Conference

Publications

Blog

Update on Patient-Focused Drug Development Meeting on Sarcopenia

Author: Noel Lloyd

Date: April 20th, 2017

On April 6, the U.S. Food and Drug Administration held a public meeting on Patient-Focused Drug Development (PFDD) for sarcopenia. The focus of the meeting was to obtain patient perspectives on “symptoms and the daily impacts of their condition, current approaches to treatment, and decision factors taken into account when selecting a treatment.”


Alliance's Bens Will Testify on MDUFA and PDUFA Reauthorization

Author: Breanna Bishop

Date: April 3rd, 2017

On April 4, the Alliance for Aging Research’s Vice President of Public Policy Cynthia Bens will testify before the U.S. Senate Committee on Health, Education, Labor and Pensions about the reauthorization of the Prescription Drug User Fee Act and the Medical Device User Fee Act. You can watch the hearing here.


Alliance Comments on the FDA's Commitment Letter for PDUFA VI

Author: Noel Lloyd

Date: August 30th, 2016

In response to a call from the U.S. Food and Drug Administration (FDA) for feedback on its proposed Commitment Letter for the sixth reauthorization of the Prescription Drug User Fee Act (PDUFA), the Alliance for Aging Research submitted comments to the FDA for consideration.


Alliance's Bens to Participate in Symposium on Frailty

Author: Noel Lloyd

Date: March 29th, 2016

On April 7, the Alliance's Vice President of Public Policy Cynthia Bens will participate in a symposium titled "Frailty as a Baseline Stratification Parameter and Potential Therapeutic Target" at the 28th Annual EuroMeeting in Hamburg, Germany.


Participate in an Alzheimer's Disease Clinical Trial

Author: Noel Lloyd

Date: November 12th, 2015

Participating in Alzheimer's disease clinical trials is a valuable way you and your loved ones can personally impact this disease.


Two New Clinical Studies Request Volunteers

Author: Noel Lloyd

Date: August 3rd, 2015

We are sharing the following information about two new clinical studies.


Cynthia Bens Comments from MDUFA and PDUFA Meetings

Author: Noel Lloyd

Date: July 16th, 2015

Alliance Vice President of Public Policy Cynthia Bens took part in two important meetings at the U.S. Food and Drug Administration this week.


Don’t Just Act Out, Act to Increase Representation in Clinical Trials

Author: Cynthia Bens

Date: August 29th, 2014

Vice President of Public Policy Cynthia Bens talks about clinical trials.

Newsletter

Highlights from This Year in Public Policy

Date: December 9th, 2015

From Capitol Hill to the NIH to the U.S. Food and Drug Administration, it was a busy year for the Alliance on the public policy front.


America’s Ark for the Silver Tsunami: The Agency for Healthcare Research and Quality (AHRQ)

Date: August 5th, 2015

What is the Agency for Healthcare Research and Quality? And why is it vitally important to our national health care system? You'll understand why after reading this article.

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It